EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Regulation of β-Adrenergic Receptors in the Heart: A Review on Emerging Therapeutic Strategies for Heart Failure

Warisara Parichatikanond iD, Ratchanee Duangrat, Hitoshi Kurose, Supachoke Mangmool iD

Cells · 10.10.2024 · 13 (20) · 1674

DOI: 10.3390/cells13201674 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 10.10.2024. Verfasst von Warisara Parichatikanond und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Pharmacy, Mahidol University, Bangkok 10400, Thailand. Hauptthemen laut MEDLINE: Heart Failure, Receptors, Adrenergic, beta. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Council of Thailand, Mahidol University, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prolonged overstimulation of β-adrenergic receptors (β-ARs), a member of the G protein-coupled receptor (GPCR) family, causes abnormalities in the density and functionality of the receptor and contributes to cardiac dysfunctions, leading to the development and progression of heart diseases, especially heart failure (HF). Despite recent advancements in HF therapy, mortality and morbidity rates continue to be high. Treatment with β-AR antagonists (β-blockers) has improved clinical outcomes and reduced overall hospitalization and mortality rates. However, several barriers in the management of HF remain, providing opportunities to develop new strategies that focus on the functions and signal transduction of β-ARs involved in the pathogenesis of HF. As β-AR can signal through multiple pathways influenced by different receptor subtypes, expression levels, and signaling components such as G proteins, G protein-coupled receptor kinases (GRKs), β-arrestins, and downstream effectors, it presents a complex mechanism that could be targeted in HF management. In this narrative review, we focus on the regulation of β-ARs at the receptor, G protein, and effector loci, as well as their signal transductions in the physiology and pathophysiology of the heart. The discovery of potential ligands for β-AR that activate cardioprotective pathways while limiting off-target signaling is promising for the treatment of HF. However, applying findings from preclinical animal models to human patients faces several challenges, including species differences, the genetic variability of β-ARs, and the complexity and heterogeneity of humans. In this review, we also summarize recent updates and future research on the regulation of β-ARs in the molecular basis of HF and highlight potential therapeutic strategies for HF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureReceptors, Adrenergic, betaHumansAnimalsSignal TransductionAdrenergic beta-AntagonistsMyocardium

Stichwörter der Autor:innen

CaMKIIG proteinG protein-coupled receptor kinaseadenylyl cyclase (AC)cGMPheart failureβ-adrenergic receptor (β-AR)β-arrestin

Substanzen

Receptors, Adrenergic, betaAdrenergic beta-Antagonists

Autor:innen und Institutionen

  • Department of Pharmacology, Faculty of Pharmacy, Mahidol University, Bangkok 10400, Thailand.
  • Department of Pharmacology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.
  • Pharmacology for Life Sciences, Graduate School of Pharmaceutical Sciences, Tokushima University, Tokushima 770-8505, Japan.
  • Pharmacology for Life Sciences, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8505, Japan.
  • Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.

ORCID-Profile: Warisara Parichatikanond, Supachoke Mangmool

Förderung

  • National Research Council of Thailand
  • Mahidol University
  • National Research Foundation of Korea
  • Chiang Mai University
  • Japan Society for the Promotion of Science
  • JSPS KAKENHI
  • Korean government (MSIP)

Zitieren

APA

Parichatikanond, W., Duangrat, R., Kurose, H., & Mangmool, S. (2024). Regulation of β-Adrenergic Receptors in the Heart: A Review on Emerging Therapeutic Strategies for Heart Failure. Cells, 13(20), 1674. https://doi.org/10.3390/cells13201674

Vancouver

Parichatikanond W, Duangrat R, Kurose H, Mangmool S. Regulation of β-Adrenergic Receptors in the Heart: A Review on Emerging Therapeutic Strategies for Heart Failure. Cells. 2024;13(20):1674. doi:10.3390/cells13201674

BibTeX
@article{Parichatikanond2024,
  author = {Parichatikanond, Warisara and Duangrat, Ratchanee and Kurose, Hitoshi and Mangmool, Supachoke},
  title = {Regulation of β-Adrenergic Receptors in the Heart: A Review on Emerging Therapeutic Strategies for Heart Failure},
  journal = {Cells},
  year = {2024},
  volume = {13},
  number = {20},
  pages = {1674},
  doi = {10.3390/cells13201674}
}
Kostenlos starten →